Quantifying patient- and hospital-level antimicrobial resistance dynamics in

Quentin Leclerc, Alastair Clements, Helen Dunn, James Hatcher, Jodi A Lindsay, Louis Grandjean, Gwenan M Knight

Abstract read

In one paragraph

Article in Journal of medical microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Tools and challenges in the use of routine clinical data for antimicrobial resistance surveillance.npj antimicrobials and resistance · 2025
Review
Unveiling the dynamics of antimicrobial utilization and resistance in a large hospital network over five years: Insights from health record data analysis.PLOS digital health · 2023
Article

4 · The record

Corrections and comments

Update of
Quantifying patient- and hospital-level antimicrobial resistance dynamics in2023

5 · Who and what money

Authors and funding

7 authors.

Quentin LeclercCentre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK.

Alastair ClementsCentre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK.

Helen DunnGreat Ormond Street Hospital, London, UK.

James HatcherGreat Ormond Street Hospital, London, UK.

Jodi A LindsayInstitute for Infection and Immunity, St George's University of London, London, UK.

Louis GrandjeanDepartment of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, UK.

Gwenan M KnightCentre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK.

Funding

Medical Research Council MR/P014658/1

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsStaphylococcal InfectionsChildDrug Resistance, BacterialHospitals, PediatricHumansMethicillinRoutinely Collected Health DataStaphylococcus aureusAnti-Bacterial AgentsMethicillindiversityhospital dataresistance dynamicsS. aureus

Identifiers

PMID37431889

DOI10.1099/jmm.0.001724

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.